Global Polymerase Chain Reaction (Pcr) Market Research Report, 2013-2019

Polymerase chain reaction (PCR) is a simple and rapid method to amplify DNA, i.e. produce a large number of clones of DNA molecules from a sample. In the fields of molecular biology or molecular pathology, where the sample quality might be poor, PCR has become the most widely used technology. The market for PCR technology includes reagents and consumables, instruments, software and services. The reagents and consumables segment accounts for the largest share in this market, followed by the instruments segment. Growth of this market is fuelled by increased usage and wide applications in the fields of life sciences research, clinical diagnostics and drug discovery. Increasing number of patients suffering from cancer, AIDS and hepatitis and heavy investments in medical R&D are some other factors driving growth of this market.

Read More @ http://www.transparencymarketresearch.com/pcr-technologies.html

A paradigm shift in drug discovery technologies, from plant-derived chemicals to cellular and genetic components, has provided great impetus to the use of PCR technology. Pharmacogenomics processes are now increasingly utilizing genotyping and phenotyping methods for identification of clinical biomarkers. However, this market is characterized mainly by rapid technological advancements, indicating a highly competitive scenario for market players. Competitive pricing pressures have led to an intense struggle amongst key players, for retaining their market shares.

Various PCR techniques available in the market include Q-PCR, Reverse-Transcription PCR (RT-PCR), Inverse PCR and Assembly PCR, of which Q-PCR is the fastest growing technique in the market. Different application areas include research, DNA sequencing, tissue typing, infectious diseases, gene expression, diagnosis and others.

Some of the major players in this market are Abbott Laboratories, Affymetrix Inc., Agilent Technologies, Beckman Coulter Inc., Bio-Rad, Becton, Dickinson and Co., GE Healthcare,...